Abstract CT182: Neoadjuvant immuno-radiotherapy (NIRT) in head and neck cancer: Phase I/Ib study of combined PD-1/SBRT prior to surgical resection
Rom S. Leidner(Providence Portland Medical Center), Marka R. Crittenden(Providence Portland Medical Center), Marcus Couey(Providence Portland Medical Center), Dawn Brucker(Providence Portland Medical Center), Brendan D. Curti(Providence Portland Medical Center), Lessli Rushforth(Providence Portland Medical Center), R. Bryan Bell(Takara (United States)), Amber L. Watters(Providence Portland Medical Center), Michael J. Gough(Providence Portland Medical Center), Kristina H. Young(Providence Portland Medical Center), Carlo Bifulco(Providence Health & Services), Ashish Patel(Providence Portland Medical Center), Brian Piening(Providence College), Hong Xiao(Fujian Medical University), George Morris(Providence Portland Medical Center), Shorin Nemeth(Providence Portland Medical Center)
Cited by 4
Related Papers
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
|Journal of Clinical Investigation|2002|915
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803